Xu-Dong Qu

Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

Xiao‐Dong Zhu, Cheng Huang, Ying‐Hao Shen et al. · Liver Cancer · 2021 · 225 citations · Full text

Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma

Bo Zhou, Zhiping Yan, Rong Liu et al. · Radiology · 2016 · 92 citations

Surgical Oncology, Multimodality, Pharmacotherapy +20

The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma

Xu-Dong Qu, Chengshi Chen, Jianhua Wang et al. · BMC Cancer · 2012 · 86 citations · Full text

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma

Xiao‐Dong Zhu, Cheng Huang, Ying‐Hao Shen et al. · Annals of Surgical Oncology · 2022 · 66 citations · Full text

Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study

Wei‐Feng Qu, Zhen‐Bin Ding, Xu-Dong Qu et al. · BJS Open · 2022 · 55 citations · Full text